UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q


(Mark One)
[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2010 or

[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to ___________________

Commission File Number 0-22529

inTEST Corporation
(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or other jurisdiction of incorporation or organization)

22-2370659
(I.R.S. Employer Identification Number)

7 Esterbrook Lane
Cherry Hill, New Jersey 08003
(Address of principal executive offices, including zip code)

(856) 505-8800
(Registrant's Telephone Number, including Area Code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES   X       NO ____

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ____    NO ____

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ___                                                                                Accelerated filer  ___
Non-accelerated filer   ___ 
(Do not check if a smaller reporting company)                        Smaller reporting company  X    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ___    NO   X    

Number of shares of Common Stock, $.01 par value, outstanding as of the close of business on October 31, 2010:

10,345,476


 


inTEST CORPORATION

INDEX

 

 

PART I.

FINANCIAL INFORMATION

 

 

Page

Item 1.

Financial Statements

 

 

 

 

 

Consolidated Balance Sheets as of September 30, 2010 (Unaudited) and December 31, 2009

1

 

Unaudited Consolidated Statements of Operations for the three months and nine months ended
   September 30, 2010 and 2009


2

 

Unaudited Consolidated Statements of Comprehensive Earnings (Loss) for the three months and
   nine months ended September 30, 2010 and 2009


3

 

Unaudited Consolidated Statement of Stockholders' Equity for the nine months ended September 30, 2010

4

 

Unaudited Consolidated Statements of Cash Flows for the nine months ended September 30, 2010 and 2009

5

 

Notes to Consolidated Financial Statements

6 - 17

 

 

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

18 - 25

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

 

 

 

Item 4.

Controls and Procedures

26

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

27

 

 

 

Item 1A.

Risk Factors

27

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

27

 

 

 

Item 3.

Defaults Upon Senior Securities

27

 

 

 

Item 4.

(Removed and Reserved)

27

 

 

 

Item 5.

Other Information

27

 

 

 

Item 6.

Exhibits

27

 

 

Signatures

28

Index to Exhibits

28

 


 

 

PART 1. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

inTEST CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)

 Sept. 30, Dec. 31,
 2010 2009
 -------- --------
ASSETS: (Unaudited)
Current assets:
 Cash and cash equivalents $ 6,197 $ 2,647
 Trade accounts receivable, net of allowance for
 doubtful accounts of $238 and $154, respectively 7,940 5,413
 Inventories 3,188 3,064
 Prepaid expenses and other current assets  465  377
 Total current assets  17,790  11,501
Property and equipment:
 Machinery and equipment 3,224 3,377
 Leasehold improvements  581  533
 Gross property and equipment 3,805 3,910
 Less: accumulated depreciation  (3,613)  (3,613)
 Net property and equipment  192  297
Goodwill 1,656 1,656
Intangible assets, net 1,111 1,212
Restricted certificates of deposit 500 250
Other assets  222  228
 Total assets $21,471 $15,144
 ======= =======
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 Accounts payable $ 1,554 $ 2,576
 Accrued wages and benefits 1,511 653
 Accrued professional fees 405 375
 Accrued warranty 266 228
 Accrued sales commissions 628 315
 Accrued restructuring and other charges - 130
 Other accrued expenses 595 455
 Domestic and foreign income taxes payable 31 18
 Notes payable to stockholder 381 381
 Deferred rent  118  118
 Total current liabilities  5,489  5,249
Notes payable to stockholder, net of current portion 1,144 1,144
Deferred rent, net of current portion  69  157
 Total liabilities  6,702  6,550
Commitments and contingencies (Notes 9 and 11)
Stockholders' equity:
 Preferred stock, $0.01 par value; 5,000,000 shares authorized;
 no shares issued or outstanding - -
 Common stock, $0.01 par value; 20,000,000 shares authorized;
 10,464,505 and 10,193,255 shares issued, respectively 105 102
 Additional paid-in capital 25,911 25,798
 Accumulated deficit (11,843) (17,801)
 Accumulated other comprehensive earnings 1,332 1,356
 Treasury stock, at cost; 119,029 and 139,299 shares, respectively  (736)  (861)
 Total stockholders' equity  14,769  8,594
 Total liabilities and stockholders' equity $21,471 $15,144
 ======= =======

See accompanying Notes to Consolidated Financial Statements.
- 1 -

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)



 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 ------------------ ------------------
 2010 2009 2010 2009
 ------- ------- ------- -------
Net revenues $11,305 $ 6,009 $36,094 $15,076
Cost of revenues 5,853 3,577 18,737 10,425
 ------- ------- ------- -------
 Gross margin 5,452 2,432 17,357 4,651
 ------- ------- ------- -------

Operating expenses:
 Selling expense 1,444 988 4,427 3,161
 Engineering and product development
 expense 767 515 2,255 1,848
 General and administrative expense 1,555 1,161 4,689 4,219
 Restructuring and other charges - 27 - 356
 ------- ------- ------- -------
 Total operating expenses 3,766 2,691 11,371 9,584
 ------- ------- ------- -------
Operating income (loss) 1,686 (259) 5,986 (4,933)
 ------- ------- ------- -------

Other income (expense):
 Interest income 2 7 6 40
 Interest expense (18) (20) (54) (54)
 Other 24 (5) 37 (44)
 ------- ------- ------- -------
 Total other income (expense) 8 (18) (11) (58)
 ------- ------- ------- -------
Earnings (loss) before income tax
 expense (benefit) 1,694 (277) 5,975 (4,991)
Income tax expense (benefit) 16 1 17 (6)
 ------- ------- ------- -------
 Net earnings (loss) $ 1,678 $ (278) $ 5,958 $(4,985)
 ======= ======= ======= =======

Net earnings (loss) per common share-basic $0.17 $(0.03) $0.60 $(0.50)

Weighted average common shares
 outstanding-basic 10,033,034 9,982,972 10,011,173 9,971,157

Net earnings (loss) per common share-diluted $0.17 $(0.03) $0.59 $(0.50)

Weighted average common and common
 share equivalents outstanding-diluted 10,194,580 9,982,972 10,127,329 9,971,157

 

See accompanying Notes to Consolidated Financial Statements.

- 2 -


 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In thousands)
(Unaudited)


 Three Months Ended Nine Months Ended
 Sept. 30, Sept. 30,
 ------------------ -----------------
 2010 2009 2010 2009
 ------- ------- ------- -------

Net earnings (loss) $ 1,678 $ (278) $ 5,958 $(4,985)

Foreign currency translation adjustments 96 114 (24) 46
 ------- ------- ------- -------

Comprehensive earnings (loss) $ 1,774 $ (164) $ 5,934 $(4,939)
 ======= ======= ======= =======

See accompanying Notes to Consolidated Financial Statements.

- 3 -

 


inTEST CORPORATION
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
(In thousands, except share data)
(Unaudited)

 Accumulated
 Common Stock Addt'l Other Total
 ----------------- Paid-In Accumulated Comprehensive Treasury Stockholders'
 Shares Amount Capital Deficit Earnings Stock Equity
 ---------- ------ -------- ----------- ------------- -------- -------------

Balance, January 1, 2010 10,193,255 $ 102 $25,798 $(17,801) $1,356 $(861) $ 8,594

Net earnings - - - 5,958 - - 5,958

Other comprehensive loss - - - - (24) - (24)

Amortization of deferred
 compensation related to
 restricted stock - - 166 - - - 166

Issuance of non-vested
 shares of restricted stock 273,750 3 (3) - - - -

Forfeiture of non-vested
 shares of restricted stock (2,500) - - - - - -

Issuance of 20,270 shares of
 treasury stock to satisfy
 profit sharing liability - - (50) - - 125 75
 ---------- ----- ------- -------- ------ ----- -------

Balance, September 30, 2010 10,464,505 $ 105 $25,911 $(11,843) $1,332 $(736) $14,769
 ========== ===== ======= ======== ====== ===== =======

See accompanying Notes to Consolidated Financial Statements.

- 4 -


 

 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)
(Unaudited)


 Nine Months Ended
 Sept. 30,
 ------------------
 2010 2009
 ------- -------

CASH FLOWS FROM OPERATING ACTIVITIES
 Net earnings (loss) $ 5,958 $(4,985)
 Adjustments to reconcile net earnings (loss) to net cash
 provided by (used in) operating activities:
 Depreciation and amortization 281 389
 Foreign exchange loss 10 113
 Amortization of deferred compensation related to restricted stock 166 100
 Profit sharing expense funded through the issuance of treasury stock 75 -
 (Gain) loss on disposal of property and equipment (5) 33
 Proceeds from sale of demonstration equipment, net of gain 8 3
 Changes in assets and liabilities:
 Trade accounts receivable (2,540) (116)
 Inventories (131) 963
 Prepaid expenses and other current assets (89) 336
 Restricted certificates of deposit (250) (250)
 Other assets 1 661
 Accounts payable (1,025) 420
 Accrued wages and benefits 865 (779)
 Accrued professional fees 31 (56)
 Accrued warranty 38 (42)
 Accrued sales commissions 314 140
 Accrued restructuring and other charges (130) (136)
 Other accrued expenses 141 (78)
 Domestic and foreign income taxes payable 13 (159)
 Deferred rent (88) (88)
 ------- -------
Net cash provided by (used in) operating activities 3,643 (3,531)
 ------- -------

CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of property and equipment (84) (61)
 ------- -------
Net cash used in investing activities (84) (61)
 ------- -------

CASH FLOWS FROM FINANCING ACTIVITIES
 Repayment of capital lease obligations - (6)
 ------- -------
Net cash used in financing activities - (6)
 ------- -------
Effects of exchange rates on cash (9) (361)
 ------- -------
Net cash provided by (used in) all activities 3,550 (3,959)
Cash and cash equivalents at beginning of period 2,647 7,137
 ------- -------
Cash and cash equivalents at end of period $ 6,197 $ 3,178
 ======= =======

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of non-vested shares of restricted stock $ 448 $ -
Forfeitures of non-vested shares of restricted stock $ (11) $ (64)

Cash payments for:
 Domestic and foreign income taxes $ 1 $ 160
 Interest - 3

See accompanying Notes to Consolidated Financial Statements.

- 5 -